Literature DB >> 17062230

Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.

Yanai Ben-Gal1, Yaron Moshkovitz, Nachum Nesher, Gideon Uretzky, Rony Braunstein, Alberto Hendler, Einat Zivi, Itzhak Herz, Rephael Mohr.   

Abstract

BACKGROUND: Reduction of restenosis and reinterventions was recently reported with percutaneous interventions (PCI) with drug-eluting stents (Cypher). This study compares results of Cypher (Cordis, Miami Lakes, FL) stenting and surgical revascularization in diabetic patients.
METHODS: From January 2002 to January 2005, 518 consecutive diabetic patients underwent myocardial revascularization; 176 by PCI incorporating Cyphers and 342 treated surgically. Single-vessel patients in the surgical group were treated with the left internal thoracic artery (ITA) and most multivessel patients were treated with two ITAs. After matching for age, sex, right system revascularization, and extent of coronary disease, two groups (86 patients each) were used to compare the two revascularization modalities.
RESULTS: Both groups were similar; however, left main, poor ejection fraction, total occlusion, and bifurcation lesions were more prevalent in the surgical group, and in-stent restenosis in the PCI group. The mean number of coronary vessels treated was higher in the surgical group (2.05 vs 1.6, p < 0.001). Mean follow-up was 18 months. Overall mortality (early and late) was 2.3% and 3.5% in the Cypher and surgical groups, respectively (p = 0.65). Angina returned in 39.5% of the Cypher group and 15.1% of the surgical group, p < 0.001. There were 25 reinterventions in the Cypher group compared with five in the surgical group (p = 0.010). The Cox proportional hazard model revealed assignment to the Cypher group to be the only independent predictor of reangina (odds ratio [OR] 3.26, 95% confidence interval [CI] 1.63 to 6.53) and reintervention (OR 4.17, 95% CI 1.92 to 20.83).
CONCLUSIONS: Despite improved results of PCI with Cyphers, midterm clinical outcome of diabetic patients treated surgically is better.

Entities:  

Mesh:

Year:  2006        PMID: 17062230     DOI: 10.1016/j.athoracsur.2006.05.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Outcomes of second revascularization procedures after stent implantation.

Authors:  Richard P Konstance; Eric L Eisenstein; Kevin J Anstrom; Linda K Shaw; Robert M Califf; Robert A Harrington; David B Matchar; Kevin A Schulman; David F Kong
Journal:  J Med Syst       Date:  2008-04       Impact factor: 4.460

2.  The effect of diabetes on surgical versus percutaneous left main revascularization outcomes: a systematic review and meta-analysis.

Authors:  Marc-André d'Entremont; Ryuichiro Yagi; Soziema J S Salia; Shuqi Zhang; Lamyaa Shaban; Yakubu Bene-Alhasan; Stefania Papatheodorou; Étienne L Couture; Thao Huynh; Michel Nguyen; Rikuta Hamaya
Journal:  J Cardiothorac Surg       Date:  2022-04-01       Impact factor: 1.637

3.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary artery disease and diabetic nephropathy: a single center experience.

Authors:  Ki Sun Bae; Hyeong Cheon Park; Byung Seung Kang; Jong Won Park; Nu Ri Chon; Kyung Jin Oh; Young Won Yoon; You Sun Hong; Sung Kyu Ha
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 3.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.